Discover 779 paid clinical trials in Buffalo, New York. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 779
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
for
Multiple Myeloma, Myeloma, Myeloma Multiple
Location: Toronto, Philadelphia PA, Hackensack NJ, New York NY,
Sponsor: K36 Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05651932
Phase 1, Recruiting
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
Location: Toronto, Cleveland OH, Pittsburgh PA, Detroit MI,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06586515
Phase 1, Recruiting
First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
for
Advanced Solid Tumors, HNSCC, SCLC, NSCLC,
Location: Toronto, Cleveland OH, Columbus OH, New Haven CT,
Sponsor: Tubulis GmbH
Sex: All
Age: 18+
Code: NCT06657222
Phase 1, Phase 2, Recruiting
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
for
Urinary Bladder Neoplasms, Neoplasm Metastasis,
Location: Toronto, Rochester NY, Pittsburgh PA, Detroit MI,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT05614739
Phase 1, Recruiting
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Toronto, Oshawa, Canton OH, Detroit MI, Albany NY,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07518186
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of Amivantamab and Olomorasib Combination Therapy in Participants With Metastatic Non-Small Cell Lung Cancer
for
Carcinoma, Non-Small-Cell Lung
Location: Toronto, Fairfax VA, New York NY
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07227025
Phase 1, Phase 2, Recruiting
A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Toronto, Baltimore MD, Hackensack NJ, New York NY,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT05372354
Phase 1, Phase 2, Recruiting
Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients
for
Lung Transplant
Location: Toronto, Cleveland OH, Baltimore MD, Philadelphia PA,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 12+
Code: NCT06476132
Phase 2, Recruiting
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II
for
Refractory Angina
Location: Toronto, Cleveland OH, Pittsburgh PA, Detroit MI,
Sponsor: Shockwave Medical, Inc.
Sex: All
Age: 18+
Code: NCT05102019
Recruiting
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Comparing the Effectiveness of the Immunotherapy Agents Rituximab or Mosunetuzumab in Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma, NORM Trial
for
Nodular Lymphocyte Predominant B-Cell Lymphoma,
Location: Toronto, Basking Ridge NJ, Montvale NJ, New York NY,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05886036
Phase 2, Recruiting
A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer
for
Advanced or Metastatic Colorectal Cancer
Location: Toronto, Ottawa, Ann Arbor MI, New York NY,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT05379595
Phase 1, Phase 2, Recruiting
SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma
Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial
for
Advanced Ovarian Carcinoma,
Location: Toronto, Cleveland OH, Bethlehem PA, New York NY,
Sponsor: M.D. Anderson Cancer Center
Sex: Female
Age: 18+
Code: NCT04575935
Phase 3, Recruiting
A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)
for
Metastatic Colorectal Cancer
Location: Toronto, Sterling Heights MI, Ottawa, White Plains NY,
Sponsor: EMD Serono Research & Development Institute, Inc.
Sex: All
Age: 18+
Code: NCT07549412
Phase 3, Recruiting
Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial